QIPCM is a central repository for imaging data and analysis tools to ease the management of your multi-centre trial.


The Quantitative Imaging for Personalized Cancer Medicine (QIPCM) program provides end-to-end testing and analysis support for clinical trials to improve consistency and reliability in clinical trial data.


QIPCM provides international multi-centre clinical trials with a central repository for large volume functional and dynamic imaging data.

Use Cases

Explore some of the ways in which QIPCM can help facilitate various types of clinical trials: logistically, easily, accurately, and securely.

About UHN

University Health Network (UHN) is Canada’s largest research hospital. It is fully affiliated with the University of Toronto and comprises four academic hospitals, an education institute and seven research institutes. The scope of research and complexity of cases at UHN has made it a national and international source for discovery, education and patient care. UHN leads major research programs in cardiology, transplantation, neuroscience, oncology, surgical innovation, infectious disease, genomic medicine, rehabilitation medicine and much more.

QIPCM is an advanced imaging core lab situated within the Techna Institute, a UHN research institute dedicated to accelerating the development and exploitation of technology for health..


View our recent News Articles, Publications and other Useful Links.

QIPCM represents a central hub that helps building a strong bridge for investigators, provides them a sense of national community, which is important for advancement of our research together.

Our clinical trial investigating the role of multi-parametric MRI in predicting tumour response generated a large amount of imaging data. QIPCM provided a customised workflow on a stable software platform backed up by exceptional technical support that enabled us to perform accurate and efficient image analysis.

QIPCM has been instrumental in providing the image collection and analysis tools for my multi-site clinical trial. The group has worked with my team to first calibrate the SPECT-CT scanners from each institution and then develop a personalized dosimetry tool for SPECT imaging. QIPCM is always quick to answer my questions and concerns and have made this complicated trial easier to manage.


For our newsletter to stay up to date with QIPCM!


For more information or a request for services please use our contact form, phone number or email address to get in touch with Julia at QIPCM.

Email: Julia.Publicover@rmp.uhn.ca

This contact form is deactivated because you refused to accept Google reCaptcha service which is necessary to validate any messages sent by the form.
© Copyright - QIPCM - website designed/developed by Techna